Plasma Therapy — TrayLIFE PRP

TrayLIFE plasma therapy is an autologous platelet-rich plasma (PRP) treatment using a branded single-use sterile kit system for blood collection, centrifuge processing, and platelet activation — distinct from generic PRP in its standardised preparation protocol. At Top Laser Olomouc, a small blood sample is drawn, processed in the clinic's centrifuge to concentrate growth-factor-rich plasma, and then injected via fine needle into the face, neck, or décolletage. Activated platelets release PDGF, TGF-β, VEGF, and other growth factors at the injection site, stimulating fibroblast activity, accelerating dermal collagen synthesis, and improving microcirculation. Because the treatment uses the patient's own blood, there is no risk of allergic reaction or foreign-body response. Results include visibly smoother skin texture, improved firmness, and enhanced radiance, with the recommended maintenance cycle of every six months.

Platelet-rich plasma therapy has been established in sports medicine and wound healing for decades; its application in aesthetic dermatology exploits the same regenerative biology. The TrayLIFE system — the specific kit used at Top Laser Olomouc — standardises each step in a certified, single-use sterile format: the collection tube, centrifuge speed profile, and activation protocol are pre-engineered to consistently yield plasma with a platelet concentration three to five times baseline blood levels, ensuring reproducible biological activity. The procedure begins with a standard blood draw — typically 8–20 ml from the antecubital vein — using the TrayLIFE collection kit. The tube is placed in the clinic's centrifuge and spun for a controlled duration, separating red blood cells, white blood cells, and the platelet-poor plasma layer from the platelet-rich plasma fraction. The PRP layer is carefully extracted; some protocols add an activation step using calcium chloride or thrombin to pre-trigger platelet degranulation and accelerate growth factor release at the injection site. The activated PRP is then drawn into injection syringes and delivered via fine 30–32-gauge needles in a serial puncture pattern across the treatment zone. For the face, injections target the papillary dermis at approximately 1 mm depth across the cheeks, periorbital area, nasolabial region, forehead, and chin — the zones most affected by volume loss and collagen thinning. Neck and décolletage treatments address the characteristic horizontal creasing and skin laxity in these areas. Growth factors released from activated platelets — primarily PDGF (platelet-derived growth factor), TGF-β (transforming growth factor), VEGF (vascular endothelial growth factor), and EGF (epidermal growth factor) — bind to fibroblast surface receptors and upregulate collagen I and III synthesis, hyaluronic acid production, and angiogenesis. The clinical result is a gradual improvement in skin density, hydration, and radiance over four to eight weeks following treatment, with the full benefit building through repeated sessions. Because TrayLIFE plasma contains no synthetic materials — only the patient's own processed blood — there is no allergy risk and no skin testing required, making it suitable even for patients who prefer to avoid pharmaceutical injectables. The complete procedure takes 20–30 minutes. Mild injection-site swelling and occasional small bruises are the only expected side effects, resolving within two to four days. Dr. Nyklová Skřivánková's dermatological background ensures correct needle depth and pattern selection for each facial zone. A maintenance treatment every six months sustains results; some patients extend to annual sessions after an initial intensive two-treatment course.